Horizon Pharma reported $673.31M in Trade Debtors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Aerie Pharmaceuticals AERI:US $ 68.08M 4.46M
ALKERMES ALKS:US 262.33M 7.83M
Amgen AMGN:US $ 5327M 250M
AstraZeneca AZN:LN 789.49B 100.39B
Bristol Myers Squibb BMY:US $ 12540M 4029M
Cara Therapeutics CARA:US $ 9.17M 5.54M
Coherus Biosciences CHRS:US $ 115.71M 1.33M
Eli Lilly And LLY:US $ 7672.4M 133.3M
Endo International Ordinary Shares ENDP:US $ 498.9M 13.24M
Horizon Pharma HZNP:US $ 673.31M 11.2M
JAZZ PHA JAZZ:US $ 594.03M 21.64M
Novartis NOVN:VX 8.91B 232M
Pacira Pharmaceuticals PCRX:US $ 91.1M 1M
Perrigo Ordinary Shares PRGO:US $ 777.1M 65.3M
Prestige Brands PBH:US $ 145.45M 6.12M
Revance Therapeutics RVNC:US $ 5.59M 1.12M
Supernus Pharmaceuticals SUPN:US $ 158.06M 12.91M
Takeda 4502:JP Y 794092M 69715M
Teva Pharmaceutical Industries TEVA:US $ 4471M 218M
Valeant Pharmaceuticals VRX:CN $ 2117.44M 551.44M
Xeris Pharmaceuticals Inc XERS:US $ 25.76M 2.37M
Zoetis ZTS:US $ 1291M 69M